Cannabis News Box

Biotech company signs $122 million deal to produce pharmaceutical-worthy weed

Biotech company signs $122 million deal to produce pharmaceutical-worthy weed

Eight cannabis compounds will now be produced by Gingko in Cronos' labs
Bethan Rose Jenkins, Cannabis News Writer/Editorial September 21, 2018

A biotech startup that specializes in designing custom microbes for customers across various markers has revealed its plans to produce lab-grown cannabis. Gingko Bioworks will join forces with Cronos...

Load More Stories
Activate Search
Gingko-Cronos